![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 28, 2021 10:58:43 AM
Total volume four a company if they had a nose and a high quality multi port the multiport volume overall will do 60+ percent of the cases easily. Any valuation will reflect that …
A good multi port can do ANY procedure. SP, including Enos CANNOT … even with the flexible arms. Add the fact that ENOS only has two arms and it further limits it’s capabilities.
I suggest talking to real surgeons before making these ridiculous claims. Your claims either come from blindly supporting this stock or complete lack of understanding of the needs of triangulation in more complex procedures.
But hey, 2 or 3 times ($6-9B) The $3 Billion CMR valuation seems reasonable LOL.
BelizeMe
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM